$12.930
-0.988 (-7.64%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CGEM Prediction & Forecast by Similar Chart Analysis
Alphio's CGEM stock price prediction model matches the current Cullinan Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $12.92 (-0.06%). The 1-week path is $12.11 (-6.36%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Cullinan Therapeutics Inc Stock?
Cullinan Oncology Inc (CGEM) is currently trading at $12.93, significantly below analyst price targets of $35 to $47, indicating potential upside. However, the stock has a low RSI of 20.428, suggesting it is oversold, but recent performance shows a troubling 5-day change of -16.74%. The company is facing challenges with safety concerns in its pipeline, which could impact future performance. Therefore, while there is potential for recovery, the risks associated with the pipeline updates and recent stock pressure suggest a cautious approach is warranted.
CGEM stock price ended at $12.93 on Friday, after losing -7.64%
Cullinan Therapeutics Inc (CGEM) last closed at $12.93, losing -7.64%. These facts feed the 1-day and 1-week CGEM price prediction above.
Forecast Drivers
Cullinan Therapeutics Inc (CGEM) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches CGEM, ranked by similarity.
Seasonality analysis for CGEM
Historically the probability of a positive October return for CGEM is 60.34%. February offers the highest probability of a positive month at 67.24%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CGEM
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $7.88 | $8.95 | $10.56 | -30.78% |
| Nov 2026 | $6.16 | $6.72 | $6.72 | -48.02% |
| Dec 2026 | $7.28 | $7.72 | $8.69 | -40.31% |
In 2026, Cullinan Therapeutics Inc (CGEM) is projected to range from $6.16 to $10.56.
Cullinan Therapeutics Inc 2026 monthly forecast
In Oct 2026, Cullinan Therapeutics Inc is projected to average $8.95, with a low of $7.88 and high of $10.56.
In Nov 2026, Cullinan Therapeutics Inc is projected to average $6.72, with a low of $6.16 and high of $6.72.
In Dec 2026, Cullinan Therapeutics Inc is projected to average $7.72, with a low of $7.28 and high of $8.69.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.